AR025638A1 - Conjugados de glucopiranosidas de 2-(4-hidroxi-fenil)-3-metil-1-/4-(2-amin-1-il-etoxi)-bencil/-1h-indol-5-oles - Google Patents

Conjugados de glucopiranosidas de 2-(4-hidroxi-fenil)-3-metil-1-/4-(2-amin-1-il-etoxi)-bencil/-1h-indol-5-oles

Info

Publication number
AR025638A1
AR025638A1 ARP000104778A ARP000104778A AR025638A1 AR 025638 A1 AR025638 A1 AR 025638A1 AR P000104778 A ARP000104778 A AR P000104778A AR P000104778 A ARP000104778 A AR P000104778A AR 025638 A1 AR025638 A1 AR 025638A1
Authority
AR
Argentina
Prior art keywords
glucopiranosid
etoxi
bencil
hydroxi
oles
Prior art date
Application number
ARP000104778A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR025638A1 publication Critical patent/AR025638A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Provee estrogenos selectivos de formula 1 que tienen la estructura en la cual R1 y R2 son independientemente hidrogeno, una cadena alquilo C1-6, bencilo,acilo C2-7, benzoilo de formula 2 o 3, X es hidrogeno, alquilo C1-6, CN, halogeno, trifluormetilo, o tiolaquilo C1-6; n = 1-3; con la condicion de que por lomenos R1 y R2 no sea hidrogeno, una cadena alquilo C1-6, bencilo, acilo C2-7, o benzoilo; o una sal farmacéuticamente aceptable de los mismos. También seprovee una composicion farmacéutica que comprende un compuesto de formula 1.
ARP000104778A 1999-09-13 2000-09-12 Conjugados de glucopiranosidas de 2-(4-hidroxi-fenil)-3-metil-1-/4-(2-amin-1-il-etoxi)-bencil/-1h-indol-5-oles AR025638A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39424099A 1999-09-13 1999-09-13

Publications (1)

Publication Number Publication Date
AR025638A1 true AR025638A1 (es) 2002-12-04

Family

ID=23558135

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104778A AR025638A1 (es) 1999-09-13 2000-09-12 Conjugados de glucopiranosidas de 2-(4-hidroxi-fenil)-3-metil-1-/4-(2-amin-1-il-etoxi)-bencil/-1h-indol-5-oles

Country Status (25)

Country Link
EP (1) EP1212335B1 (es)
JP (1) JP2003509435A (es)
KR (1) KR100653570B1 (es)
CN (1) CN1196708C (es)
AR (1) AR025638A1 (es)
AT (1) ATE316093T1 (es)
AU (1) AU764436B2 (es)
BR (1) BR0013943A (es)
CA (1) CA2382683A1 (es)
CY (1) CY1104970T1 (es)
CZ (1) CZ298862B6 (es)
DE (1) DE60025630T2 (es)
DK (1) DK1212335T3 (es)
EA (1) EA005371B1 (es)
ES (1) ES2254215T3 (es)
HK (1) HK1044777B (es)
HU (1) HUP0202679A3 (es)
IL (2) IL148273A0 (es)
MX (1) MXPA02002654A (es)
NO (1) NO322250B1 (es)
NZ (1) NZ517645A (es)
PL (1) PL354179A1 (es)
TW (1) TWI287018B (es)
WO (1) WO2001019839A1 (es)
ZA (1) ZA200201876B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2454059A1 (en) * 2001-07-19 2003-01-30 Cv Therapeutics, Inc. Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
WO2006027987A1 (ja) * 2004-09-06 2006-03-16 Kissei Pharmaceutical Co., Ltd. 排尿障害の予防又は治療薬
RU2011145811A (ru) * 2009-04-13 2013-05-20 Сандоз Аг Способы синтеза базедоксифенацетата и его промежуточных продуктов
CN101857617A (zh) * 2010-04-28 2010-10-13 中国海洋大学 喹唑啉类糖衍生物及其制备方法和应用
CN102690225B (zh) * 2012-04-11 2014-12-24 南京友杰医药科技有限公司 巴多昔芬的合成方法
CN104798294B (zh) * 2012-11-22 2018-09-25 艾默生电气公司 电机、定子和压缩机，以及制造它们的方法
CN104151265B (zh) * 2013-05-13 2016-10-05 上海医药工业研究院 醋酸巴多昔芬中间体的制备方法
CN104725334A (zh) * 2013-12-20 2015-06-24 北京蓝贝望生物医药科技股份有限公司 (4-(2-(氮杂环庚烷-1-基)乙氧基)苯基)甲醇的制备方法
CN105085365B (zh) * 2014-05-12 2018-06-19 四川科伦药业股份有限公司 醋酸巴多昔芬及其中间体的制备方法
CN107033062B (zh) * 2017-03-24 2019-10-29 梯尔希（南京）药物研发有限公司 一种巴多昔芬衍生物的制备方法
CN107400087B (zh) * 2017-09-15 2019-12-13 济南美高生物医药科技有限公司 一种1-(2-(4-(氯甲基)苯氧基)乙基)氮杂环庚烷盐酸盐的制备方法
CN111196831B (zh) * 2020-01-20 2023-05-09 山西医科大学 一种呋喃酚葡萄糖醛酸结合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3821148A1 (de) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
WO1993023374A1 (en) * 1992-05-08 1993-11-25 Otsuka Pharmaceutical Factory, Inc. Indole derivative
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
EP0746544B1 (en) * 1994-02-22 1998-09-09 Merrell Pharmaceuticals Inc. Novel indole derivatives useful to treat estrogen-related neoplasms and disorders
US6723739B1 (en) * 1994-05-20 2004-04-20 Eli Lilly And Company Glucopyranoside benzothiophenes
DE4426625A1 (de) * 1994-07-27 1996-03-14 Schering Ag 2-Phenylindole, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
PT802183E (pt) * 1996-04-19 2002-03-28 American Home Prod Agentes estrogenicos
ES2281937T3 (es) * 1997-10-15 2007-10-01 Wyeth Nuevas ariloxi-alquil-dialquilaminas.
ID24568A (id) * 1997-11-06 2000-07-27 American Home Prod Kontrasepsi oral yang mengandung anti-estrogen plus progestin

Also Published As

Publication number Publication date
KR20020027643A (ko) 2002-04-13
CY1104970T1 (el) 2010-03-03
EP1212335B1 (en) 2006-01-18
NO322250B1 (no) 2006-09-04
EA200200358A1 (ru) 2002-08-29
EA005371B1 (ru) 2005-02-24
NZ517645A (en) 2003-09-26
HK1044777A1 (en) 2002-11-01
WO2001019839A1 (en) 2001-03-22
CN1196708C (zh) 2005-04-13
ATE316093T1 (de) 2006-02-15
CZ298862B6 (cs) 2008-02-27
HUP0202679A2 (hu) 2003-01-28
NO20021203L (no) 2002-03-12
IL148273A0 (en) 2002-09-12
BR0013943A (pt) 2002-05-14
DE60025630T2 (de) 2006-08-10
MXPA02002654A (es) 2002-07-30
PL354179A1 (en) 2003-12-29
CN1382151A (zh) 2002-11-27
ZA200201876B (en) 2003-08-27
DE60025630D1 (de) 2006-04-06
AU7128400A (en) 2001-04-17
ES2254215T3 (es) 2006-06-16
HUP0202679A3 (en) 2003-04-28
JP2003509435A (ja) 2003-03-11
TWI287018B (en) 2007-09-21
CZ2002881A3 (cs) 2003-01-15
NO20021203D0 (no) 2002-03-12
IL148273A (en) 2007-03-08
EP1212335A1 (en) 2002-06-12
DK1212335T3 (da) 2006-03-20
HK1044777B (zh) 2006-04-13
KR100653570B1 (ko) 2006-12-05
CA2382683A1 (en) 2001-03-22
AU764436B2 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
AR025638A1 (es) Conjugados de glucopiranosidas de 2-(4-hidroxi-fenil)-3-metil-1-/4-(2-amin-1-il-etoxi)-bencil/-1h-indol-5-oles
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
RU2002110295A (ru) Ингибиторы фактора Ха
FR08C0004I2 (fr) Composition orale d' une dose pour une libération prolongée
UY26754A1 (es) Derivados de la 1, 3, 8, -triaza-spiro (4,5) decan-4-ona
RU2002109814A (ru) Новые производные аминодикарбоновых кислот, обладающие фармацевтическими свойствами
DE69814375D1 (de) Fungizide trifluoromethylalkylamino-triazolopyrimidine-derivate
NO20013671L (no) Substituerte bisycliske derivater nyttige som anticancer midler
AR064896A2 (es) Composicion farmaceutica no higroscopica
LU92366I2 (fr) Teriflunomide, son stéréoisomère et leurs sels pharmaceutiquement acceptables
EA199900749A1 (ru) Фармацевтическая композиция
DE69500652T2 (de) Nefazodon-Salze mit verbesserter Auflösungsgeschwindigkeit
NO20015897D0 (no) Indolylpiperidinderivater som antihistaminiske og antiallergiske midler
DE60230127D1 (de) Inhibitoren von integrin alpha-v-beta-6
DE69738672D1 (de) Vakzinzusammensetzung gegen malaria
DK0579833T3 (da) Ethanolaminderivater med anti-pollakisuria-virkning
CO5170458A1 (es) Suspension de ziprasidona
NO20013440D0 (no) Sammensetninger med forbedret stabilitet
DE60017425D1 (de) Antitranspirant zusammensetzung enthaltend mikroemulsionen
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
UY26329A1 (es) Antagonistas de los receptores de vitronectina
CO5040014A1 (es) Mezclas fungicidas
ITTO20010028A0 (it) Metodo per aumentare l'attivita' antitumorale di una sostanza contenente amigdalina, composizione contenente una sostanza con contenuto aume
AR023528A1 (es) Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica

Legal Events

Date Code Title Description
FB Suspension of granting procedure